From Buzzword to Clinical Tool: Setting the Record Straight on AI in the Life Sciences

Artificial intelligence (AI) far too often pops up as a term used vaguely to refer to any process that appears to involve more computers than it did twenty years ago. But concrete examples of how this informatics technology can improve fields like life sciences are harder to come by. I recently spoke to Krishnan Nandabalan, founder, CEO and president of InveniAI, which aims to use AI techniques to more quickly identify pharmacological compounds and get drugs to patients faster, to get the full picture. Ruairi Mackenzie (RM): How would you like to set the record straight about AI in the life sciences? Krishnan Nandabalan (KN): AI is used as a buzzword now.